This is an old revision of the document!
Daoud A, Gloria CJ, Taningco G, Hammerschlag MR, Weiss S, Gelling M, et al. The metabolism of Venlafaxine can be decreased when combined with Valproic Acid. The risk or severity of adverse effects can be increased when Leflunomide is combined with G17DT. Although serious CV events can occur without warning symptoms, patients should be alert for the signs and symptoms of chest pan, shortness of breath, weakness, slurring of speech, and should ask for medical advice when observing any indicative sign or symptoms. All were advised to take a diet of 1200 kcal/day. Dipyridamole may increase the anticoagulant activities of Picotamide.
